Middle East respiratory syndrome: pathogenesis and therapeutic developments
- PMID: 32201499
- PMCID: PMC7080179
- DOI: 10.2217/fvl-2018-0201
Middle East respiratory syndrome: pathogenesis and therapeutic developments
Abstract
The first case of Middle East respiratory syndrome coronavirus (MERS-CoV) was identified in the year 2012, which spread rapidly and increased to more than 2200 in 2018. This highly pathogenic virus with high mortality rate is among one of the major public health concerns. Saudi Arabia remains to be the most affected region with the majority of MERS-CoV cases, and currently, no effective drugs and vaccines are available for prevention and treatment. A large amount of information is now available regarding the virus, its structure, route of transmission and its pathophysiology. Therefore, this review summarizes the current understanding of MERS-CoV's pathogenesis, treatment options and recent scientific advancements in vaccine and other therapeutic developments, and the major steps taken for MERS prevention control.
Keywords: Arabian Peninsula; MERS; SARS; Saudi Arabia; WHO; coronavirus; global; macrophages; therapeutic; vaccine.
© 2019 Future Medicine Ltd.
Conflict of interest statement
Financial & competing interests disclosure This work was supported by King Abdulaziz City for Science and Technology and Deanship of Scientific Research, King Abdulaziz University. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. Medical writing support was provided by Scidra Consulting, INC and was funded by the authors.
Figures
Similar articles
-
Occurrence of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) across the Gulf Corporation Council countries: Four years update.PLoS One. 2017 Oct 13;12(10):e0183850. doi: 10.1371/journal.pone.0183850. eCollection 2017. PLoS One. 2017. PMID: 29028812 Free PMC article.
-
Middle East respiratory syndrome coronavirus (MERS-CoV): A review.Germs. 2019 Mar 1;9(1):35-42. doi: 10.18683/germs.2019.1155. eCollection 2019 Mar. Germs. 2019. PMID: 31119115 Free PMC article. Review.
-
Genomic Sequencing and Analysis of Eight Camel-Derived Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Isolates in Saudi Arabia.Viruses. 2020 Jun 3;12(6):611. doi: 10.3390/v12060611. Viruses. 2020. PMID: 32503352 Free PMC article.
-
High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia.mBio. 2018 Oct 30;9(5):e01985-18. doi: 10.1128/mBio.01985-18. mBio. 2018. PMID: 30377284 Free PMC article.
-
Vaccines against Middle East respiratory syndrome coronavirus for humans and camels.Rev Med Virol. 2017 Mar;27(2):e1917. doi: 10.1002/rmv.1917. Epub 2016 Oct 27. Rev Med Virol. 2017. PMID: 27786402 Free PMC article. Review.
Cited by
-
Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions.Life Sci. 2020 Sep 15;257:118102. doi: 10.1016/j.lfs.2020.118102. Epub 2020 Jul 18. Life Sci. 2020. PMID: 32687918 Free PMC article. Review.
-
A Computational Approach Identified Andrographolide as a Potential Drug for Suppressing COVID-19-Induced Cytokine Storm.Front Immunol. 2021 Jun 24;12:648250. doi: 10.3389/fimmu.2021.648250. eCollection 2021. Front Immunol. 2021. PMID: 34248936 Free PMC article.
-
COVID-19 and psoriasis: Should we fear for patients treated with biologics?Dermatol Ther. 2020 Jul;33(4):e13434. doi: 10.1111/dth.13434. Epub 2020 May 5. Dermatol Ther. 2020. PMID: 32314483 Free PMC article. Review.
-
SARS-CoV-2-Induced Immunosuppression: A Molecular Mimicry Syndrome.Glob Med Genet. 2022 Jul 14;9(3):191-199. doi: 10.1055/s-0042-1748170. eCollection 2022 Sep. Glob Med Genet. 2022. PMID: 35846107 Free PMC article.
-
Probiotics at War Against Viruses: What Is Missing From the Picture?Front Microbiol. 2020 Aug 20;11:1877. doi: 10.3389/fmicb.2020.01877. eCollection 2020. Front Microbiol. 2020. PMID: 32973697 Free PMC article. Review.
References
-
- Zhou J, Li C, Zhao G, et al. Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus. Sci. Adv. 2017;3(11):eaao4966. - PMC - PubMed
-
• Direct intragastric inoculation of Middle East respiratory syndrome coronavirus (MERS-CoV) caused a lethal infection in human dipeptidyl peptidase 4 transgenic mice.
-
- Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 2019;17(3):181–192. - PMC - PubMed
-
• Severe acute respiratory syndrome coronavirus (SARS-CoV) and MERS-CoV are two highly transmissible and pathogenic viruses that emerged in humans at the beginning of the 21st century.
-
- Zaki AM, Van Boheemen S, Bestebroer TM, et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 2012;367(9):1814–1820. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous